BIZARRE: Mirati rapeutics - You Need To See This

12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Benzinga · Jun 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

Upgrades

Benzinga · Jun 7, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Benzinga · May 27, 2022

Mirati Therapeutics: Q1 Earnings Insights

Mirati Therapeutics (NASDAQ:MRTX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Benzinga · May 4, 2022

Earnings Preview For Mirati Therapeutics

Mirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Mirati Therapeutics will report an earnings per share (EPS) of $-3.49.

Benzinga · May 3, 2022

Mirati Therapeutics's Return On Capital Employed Overview

Benzinga Pro data, Mirati Therapeutics (NASDAQ:MRTX) reported Q4 sales of $299.00 thousand. Earnings fell to a loss of $199.62 million, resulting in a 149.36% decrease from last quarter.

Benzinga · Mar 2, 2022

Preview: Mirati Therapeutics's Earnings

Mirati Therapeutics (NASDAQ:MRTX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Mirati Therapeutics will report an earnings per share (EPS) of $-3.00.

Benzinga · Feb 25, 2022